Bli medlem
Bli medlem

Du är här


BioGaia: Disclosure notice in BioGaia

Sebastian Jahreskog, BioGaia's second largest shareholder, has
announced that he has sold his shares in BioGaia to an endowment
insurance. With this, he flagged a sale. The transaction only means a
modified form of ownership and Sebastian Jahreskog intends to retain
his holdings of BioGaia.

Latest press releases from BioGaia
2016-10-25 BioGaia AB Interim Management statement 1 January - 30
September 2016

2016-10-14 BioGaia's probiotics to be launched in Kenya, Nigeria and

2016-08-17 BioGaia AB, Interim Report 1 January - 30 June 2016
For additional information please contact
Axel Sjöblad, Managing Director, BioGaia: +46 8 555 293 00

BioGaia is a healthcare company that develops, markets and sells
probiotic products with documented health benefits. The products are
primarily based on the lactic acid bacterium Lactobacillus reuteri
which has probiotic, health- enhancing effects. The class B share of
the Parent Company BioGaia AB is quoted on the Mid Cap list of the
Nasdaq OMX Nordic Exchange Stockholm.

BioGaia AB Box 3242. SE-103 64 STOCKHOLM Street address: Kungsbroplan
3A, Stockholm Telephone: +46 8 555 293 00, Corp. identity no.


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.